An Incisive, In-depth Analysis on the Dry Powder Inhaler Market
This study offers a comprehensive, 360 degree analysis on the Dry Powder Inhaler market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Dry Powder Inhaler market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.
Managed care initiatives along with an aging population demographics is propelling growth of the home health care, and fuelling adoption of self-administered drug therapies. Inhaled medicine with the help of respiratory inhalers is therefore increasingly being discerned as patient-friendly. The inhaled therapy in general, and dry powder inhalers in particular are deemed to be well-positioned for capitalizing on these trends, and evolving as major drivers for future development of the pharmaceutical sector, and commercialization of therapeutic drugs related to respiratory disorders.
Single-use Dry Powder Inhalers gaining Immense Traction owing to their Convenience and Easy Handling
There is a growing prevalence of chronic obstructive pulmonary disease and asthma across the globe, particularly in developing nations, on the back of growing pollution levels and nicotine consumption. As these nations are cost-sensitive when it comes to expensive therapies regarding various respiratory diseases, demand for low-cost devices is surging across developing countries. In some places with no health insurance facilities, patients tend to share multi-use devices as the complete system become unaffordable for them. Single-use devices are therefore witnessing increased demand as they have the potential to overcome the aforementioned challenges and offer a hygienic & clean device. A major trend being witnessed in the market is the desire for convenience and easy handling of respiratory devices. Multiple dry powder inhalers are being purchased by patients with respiratory diseases as supplementary devices for different places such as cars, job sites, and homes. With single-use dry powder inhalers, patients are enabled to carry exact dose of inhalations required in blister packs, which in turn facilitates handling and convenience.
Some essential performance characteristics of the dry powder inhalers are related to performances at varying airflows, fine particle fraction content, and dose delivery. These characteristics vary in terms of powder formulations, thereby creating the requirement for fine tuning of devices or powder formulations or both combined in order to attain optimal performance. This requirement is relatively higher in the micro-dosing dry powder inhalers. This is further expected to pave opportunities for dry powder inhaler manufacturers based on innovations and advancements.
According to a report recently published by Future Market Insights, the global dry powder inhaler market is projected to register an average expansion through the forecast period, 2017 to 2026, in terms of volume. Worldwide sales of dry powder inhales will exceed 400,000 Mn units by 2026-end.
North America to Remain Largest Market for Dry Powder Inhaler
Presence of a robust healthcare infrastructure coupled with the technologically-advanced practice, mounting number of patients with respiratory disorders, stringent guidelines by regulatory bodies regarding medical devices associated with respiratory disorder therapeutics and relatively higher healthcare spending by the government are key factors that have made North America be the most lucrative market for dry powder inhalers. Sales of dry powder inhalers in North America will exceed 160,000 Mn units by 2026-end.
Chronic obstructive pulmonary disease will continue to be the fast-expanding application of dry powder inhalers. However, dry powder inhaler sales for application in asthma will remain relatively larger than those in chronic obstructive pulmonary disease.
Key Research Findings from FMI’s Report
-
Multi-dose dry powder inhaler will continue to be dominant among products in the market
-
Hospital pharmacies will remain the fastest expanding distribution channel for dry powder inhalers
Competition Tracking
Leading players in the global market for dry powder inhalers are concentrating on developing new generation products. These market players are investing in R&D activities apropos to novel device architectures, powder formulations, and particle engineering. Development of enhanced particle properties, and efficient inhaler designs are expected to remain major strategies among the market participants. The report profiles key market participants, which include Astrazeneca Plc., 3M Company, GlaxoSmithKline Plc, Novartis AG, Cipla Ltd., Teva Pharmaceutical Industries Limited, Boehringer Ingelheim GmbH, Chiesi Farmaceutici S.p.A., MannKind Corporation, and Vectura Group Plc.
Commonly referred to as metered dose inhalers, dry powder inhalers are used as alternative devices to aerosol-based inhalers and aid in providing medication to lungs. Dry powder inhalers are highly sought-after among patients with respiratory disorders such as COPD, emphysema, bronchitis and asthma, although these devices also have potential use in diabetes mellitus therapeutics. Mounting number of people suffering from diabetes mellitus and respiratory disorders are therefore expected to remain leading revenue contributors to the global dry powder inhaler market.
Future Market Insights (FMI) has recently compiled an insightful report, titled “Global Dry Powder Inhaler Market: Global Industry Analysis (2012-2016) & Opportunity Assessment (2017-2026)”. The report delivers forecasts on the global dry powder inhaler market, and examines the market in detail, providing important dynamics affecting the market expansion. Along with the provision of information on latest market trends, restraining factors, and augmenting factors impacting growth of the market, analysis on the data regarding multiple market parameters has been included in the report.
Report Structure
The report’s initiates with a chapter titled “executive summary”, which issues a summation of global dry powder inhaler market coupled with the information on imperative market numbers such as the historical CAGR (2012-2016) and the forecast CAGR (2017-2026). These numbers rendered are associated with the market segments incorporated in the report. Trailing the executive summary is a chapter titled “overview” that incorporates the definition of “dry powder inhaler”, which succeeds an incisive market introduction. The overview chapter clearly describes the wide scope of global dry powder inhaler market. Some chapters in the report offer information on the pricing analysis coupled with the cost structure regarding the global dry powder inhaler market.
Market Taxonomy
Proceeding further, the report offers forecasts on the global market for dry powder inhaler based on a segmentation analysis. Branching the global market for dry powder inhaler into four key segments viz. application, product type, distribution channel, and region, the report delivers associated market numbers in terms of the market share comparison, Y-o-Y growth comparison, and revenue comparison. The global dry powder inhaler market has been geographically characterized by the report into Latin America, Asia-Pacific excluding Japan (APEJ), North America, Europe, Middle East & Africa (MEA), and Japan.
|
Region |
Product Type |
Distribution Channel |
Application |
|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Competition Landscape
A scrupulous analysis regarding the global dry powder inhaler market’s competition landscape has been issued in the concluding chapter of this report, incorporating information on prominent industries that significantly contribute to the market expansion. Occupancy of these market participants is tracked with the aid of an intensity map. Profiling key market participants rigorously, this chapter offers insights based on SWOT analysis, key developments, key financials, company overview, and product overview.
Research Methodology
A robust research methodology, proven & tested, has been employed by TMR’s analysts to develop the report on global dry powder inhaler market. The research methodology used has helped analysts in offering accurate insights related to the global dry powder inhaler market. It depends entirely upon the secondary and primary researches, for gaining important information associated with the market. The information compiled has then been validated by the analysts several times for ensuring the report’s authenticity, and for making it a reliable & authoritative source of reference for readers of the report.
COVID -19 : Impact Analysis
Request the coronavirus impact analysis across industries and markets
Request Covid -19 ImpactGet in touch
Our Clients
CASE STUDIES
See how our work makes an impact.
At FMI, we design strategies that are adaptive, impactful, and implementable.